Dependence is not automatically addiction
Withdrawal symptoms can develop during prescribed use. Assessment should use accurate, non-stigmatising language rather than treating every concern as compulsive use.
Prescription medicine treatment guidance
Concern about a prescribed medicine can mean several different things. Physical dependence and withdrawal can develop during appropriate prescribed use; addiction or a substance use disorder involves a wider pattern such as loss of control, compulsive use or continued use despite harm. One does not automatically prove the other.
Treatment should begin by clarifying the medicine, reason for use, prescribing history, withdrawal risk, safety and the person's goals. A qualified prescriber retains responsibility for any medication change, while psychological, addiction and recovery support may address the wider pattern where needed.
Reviewed 30 August 2026 by Craig Bilton, Founder & Clinical Director.
Insight Recovery Network is not a regulated healthcare provider, does not diagnose, prescribe or provide medical detox, and is not an emergency service.
Withdrawal symptoms can develop during prescribed use. Assessment should use accurate, non-stigmatising language rather than treating every concern as compulsive use.
A qualified prescriber must decide whether, when and how a medicine changes. IRN and recovery services do not provide a generic taper.
Where loss of control, non-prescribed use, several substances or significant harm are present, medical care may need coordinated addiction, mental-health and recovery support.
Assessment should establish the exact medicine, formulation and source; why it was started; how it is currently taken; duration; missed doses; attempts to reduce; withdrawal experiences; additional prescribed or non-prescribed medicines; alcohol or drug use; physical health; mental health; overdose or seizure history; and the person's priorities.
Physical dependence means the body has adapted and withdrawal may follow a reduction or stopping. It can occur without compulsive behaviour. Addiction or problematic use may involve craving, escalating use, taking more than intended, seeking medication from several sources, impaired control or continued use despite harm. The response should fit the actual pattern rather than a label chosen from search terms.
NICE guidance covers shared decisions and individualised withdrawal management for opioids, benzodiazepines, Z-drugs, gabapentinoids and antidepressants. The clinical issues differ by medicine and person. A fixed schedule copied from another patient, a forum or a treatment website cannot replace a prescriber who knows the history and can review the response.
The plan should identify who prescribes, how symptoms and risks are monitored, which original condition still needs treatment, what to do if symptoms become difficult and which professionals share information. Psychological or recovery support can help with routine, anxiety, pain coping, sleep, triggers and relapse prevention, but it must not quietly take over medication responsibility.
Some people need a careful medication review and prescriber-led plan without addiction treatment. Specialist drug-treatment support may become relevant when medicines are obtained outside one accountable prescription, use is compulsive, the person repeatedly takes more than intended, several sedatives or opioids are involved, overdose risk is present or attempts to change repeatedly collapse without wider support.
Assessment should remain non-judgemental. Non-prescribed tablets may not contain what the person expects, while alcohol, opioids, benzodiazepines, gabapentinoids and other sedatives can create combined risks. NHS and charitable drug services provide most UK treatment and may accept self-referral; private treatment is another route, not the only route.
A stable person with an accountable prescriber, a safe home and manageable risks may use primary care, a specialist community service and psychological or structured online support. This can keep recovery work connected to everyday life. Online support is not a prescribing service and cannot supervise withdrawal.
Residential treatment may be considered where risk or complexity cannot be managed safely at home, several substances are involved, non-prescribed use continues, the environment is unsafe or repeated community attempts have failed. The facility must demonstrate the exact medical, prescribing, pharmacy, mental-health and emergency capability required. Not every rehab can manage every medicine or withdrawal risk.
Ask who completes the medical assessment, who prescribes, which professional registrations and regulated activities apply, how the current prescriber and GP are involved, and how the service distinguishes physical dependence from addiction. Ask what it cannot manage and which symptoms or risks require hospital or specialist care.
Confirm how pain, anxiety, insomnia or another original need will be treated; how other substances and medicines are assessed; what psychological and family support is included; how consent and confidentiality work; and what the medication and recovery handover looks like after discharge. Request all costs and provider relationships in writing before committing.
The prescribing pathway and the recovery-support setting are related but not interchangeable. Choose each according to assessed need and make responsibilities explicit.
| Route | May fit when | Important limitation |
|---|---|---|
| Current prescriber or GP | Prescribed use can be reviewed safely with continuity of records and treatment for the original condition | May need specialist support for complex withdrawal, several substances or addiction |
| NHS or specialist drug service | Non-prescribed use, loss of control, opioid or sedative risk needs addiction expertise | Local access, prescribing and residential pathways vary |
| Psychological or structured recovery support | The person needs coping, routine, accountability and relapse-prevention alongside medical care | Does not prescribe, approve a taper or provide medical detox |
| Medically capable residential treatment | Home management is unsafe or complexity requires a protected setting | Verify exact prescribing and monitoring capability; a rehab label is not enough |
Insight Recovery Network provides assessment-led guidance, structured online recovery support and treatment-placement help. IRN is not a regulated healthcare provider, does not diagnose, prescribe, provide medical detox or operate the residential facilities it may discuss. A regulated provider remains responsible for clinical assessment, admission and care. Any relevant referral or provider relationship is explained before a decision.
Understand prescribed use, dependence, addiction language, risks and routes to help.
Review prescriber-led withdrawal planning and wider recovery support.
Understand why abrupt stopping can be unsafe and what an individual plan covers.
Compare maintenance and detox decisions and understand reduced-tolerance risk.
Organise medicines, withdrawal history and combination-risk questions.
Compare external providers by medical capability, setting and continuity of care.
See which clinical and practical checks affect an admission timeline.
General UK treatment information reviewed 30 August 2026. These sources support the clinical framing; they do not endorse IRN or replace individual assessment.
No. Physical dependence can develop when a medicine is taken as prescribed and means withdrawal symptoms may occur after a reduction or stopping. Addiction or problematic use involves a wider pattern such as impaired control, compulsive use or continued use despite harm. A qualified assessment should distinguish them.
Do not stop or change it because of a webpage. Contact the current prescriber, a GP or another qualified service. The safest plan depends on the medicine, dose, duration, symptoms, health, other substances and the reason it was prescribed.
Some appropriately regulated and medically staffed providers may be able to manage particular medicines and risks; others cannot. Confirm the named prescriber, medical governance, monitoring, exclusions, emergency arrangements and handover before admission.
No. IRN does not diagnose, prescribe, provide taper schedules or deliver medical detox. IRN can help organise the wider treatment questions and compare external providers while qualified clinicians retain responsibility.
Both require medicine-specific assessment. Read the opioid detox and benzodiazepine withdrawal guides, disclose all medicines, alcohol and other drugs, and seek qualified help rather than making an abrupt or self-directed change.
Discuss the medicines, withdrawal history, other substances, current prescriber and which external treatment setting could safely support the whole situation.
Discuss treatment options Start the detox assessment